International Federation of Biomedical Laboratory Science

Printer-friendly version
Meeting: 
144th session of the Executive Board<br>24 January - 1 February 2019
Agenda Item: 
6.5 Accelerating cervical cancer elimination
Statement: 

The International Federation of Biomedical Laboratory Science is a federation of National Organizations of Biomedical Laboratory Scientists (BLS). Presently, we represent 37 associations in 33 countries with more than 185,000 members. Our members are the scientists who perform, interpret and report results of routine and specialized laboratory procedures.

Effective screening and treatment of cervical pre-cancer for women aged 30 and above, can prevent women from developing cervical cancer, but many women in low- and middle-income countries are being diagnosed at a late stage and many countries lack adequate diagnostic, treatment or palliative care services.

The Biomedical Laboratory Scientist is an important member of the healthcare team in preventing disease. Screening for pre-cancer can include HPV-testing and cytology assessment, which are both in the areas of expertise of the Biomedical Laboratory Scientist, and performed in the setting of laboratory medicine. Clinicians can rely on results from our profession to diagnose and treat women.

From the meeting report of the Global Stakeholder Consultation on the Elimination of Cervical Cancer Initiative it is clear that a strategy for eliminating cervical cancer needs to build not only on existing resources and opportunities, but also on innovations in technology and services, such as more affordable point-of-care “test and treat” technology for cervical lesions. Biomedical Laboratory Scientists can provide solid advice and training also for other health care professionals where testing may be performed outside the laboratory. Since we are experiencing a shortage of BLSs we would like to take this opportunity to encourage the Executive Board to keep sight of the importance of these healthcare workers and the need to ensure an adequate supply of appropriately trained BLS.

Respectfully submitted

Anne Lindgren Berndt
President
International Federation of Biomedical Laboratory Science